Ridgepost Capital (NYSE: RPC), formerly known as P10 Inc, is a private markets solutions provider with over $50 billion in assets under management. The company invests across Private Equity, Private Credit, and Venture Capital in access-constrained strategies, with a focus on the middle and lower-middle market. Its platform encompasses three core solution types: Primary Solutions (fund-of-funds investing in diversified portfolios), Direct and Co-Investments (alongside leading general partners), and Secondary Investments (purchasing LP interests at potential discounts). The company operates 152 vehicles across its strategies, with inception dates ranging from 1980 to present. Ridgepost Capital's business model is built predominantly on recurring management and advisory fees, with fee-related revenue representing 99% of total revenue. The company serves over 5,000 investors globally across wealth managers, pension funds, endowments, financial institutions, insurance companies, and sovereign wealth funds. Its proprietary analytics database covers 6,500+ investment firms, 11,700+ funds, 52,000+ transactions, and 34,000+ private companies, providing a data-driven edge in sourcing, diligence, and monitoring. The company also includes Qualitas Funds, a Spanish subsidiary, and recently acquired Stellus Capital Management, a U.S. direct lender specializing in the lower-middle market. Updated
Nine top picks for investors looking to play a rising inflation scenario in 2018. All these companies offer exposure to the reflation potential, as well as reasonable valuations, considering their somewhat out-of-favor…
The top analyst upgrades, downgrades and other research calls from Monday include ADP, Bluebird Bio, DaVita, First Solar, Square, SunPower and US.. Steel.
The top analyst upgrades, downgrades and other research calls from Monday include Best Buy, Equifax, Gilead Sciences, MongoDB, NVIDIA, Rio Tinto, Teva Pharmaceutical and UPS.
The top analyst upgrades, downgrades and other research calls from Thursday include Arch Coal, Editas Medicine, FireEye, Generac, NextEra Energy and Under Armour.
The top analyst upgrades, downgrades and initiations seen on Tuesday include Intuitive Surgical, Restaurant Brands, Scorpio Tankers, Teva Pharmaceutical, Under Armour and Zillow.
courtesy of Delta Air LinesAs the second-quarter earnings season starts to wind down, most equity strategists at the major Wall Street firms we cover are reasonably pleased with overall corporate performance and…
Frank Golhen, via Wikimedia CommonsThe stock market has come a long way since the dark days of March 2009. The Dow Jones Industrial Average has been up 10 days in a row.…
Given the company’s horrible showing for the first quarter, the last thing MEMC Electronic Materials Inc. (NYSE: WFR) needed was to have a management shake-up. But that’s what the solar wafer maker…
Markets opened mixed this morning, with the DJIA and S&P 500 opening lower and the Nasdaq Composite opening higher. The Nasdaq was getting a big push from the very strong earnings report…
Air Products & Chemicals Inc. (NYSE: APD) makes specialty gases for industrial use, and competes with rivals Airgas Inc. (NYSE: ARG) and Praxair Inc. (NYSE: PX). Air Products reported earnings this morning…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this morning. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) named Bull of the Day at Zacks.…
These are ten of the top analyst upgrades and downgrades we have seen from Wall Street early this Thursday morning: BHP Billiton (BHP) Started as Outperform at RBC. Costco (COST) Cut to…
We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance. There are of course drug developments and other contracts awards. Below…
Ridgepost Capital (NYSE: RPC), formerly known as P10 Inc, is a private markets solutions provider with over $50 billion in assets under management. The company invests across Private Equity, Private Credit, and Venture Capital in access-constrained strategies, with a focus on the middle and lower-middle market.